Get the latest Protara Therapeutics Inc (TARA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Protara Therapeutics Inc stock news. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.

Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. These top stock picks could have big Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The View Protara Therapeutics, Inc. TARA investment & stock information. Get the latest Protara Therapeutics, Inc. TARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. View the latest Protara Therapeutics Inc. (TARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get Protara Therapeutics Inc (TARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Steadfast and tenacious in Company size: 11-50 employees Contract Recruiter at Protara Therapeutics. Protara Therapeutics Stock Forecast, "TARA" Share Price Prediction Charts. Is " Protara Therapeutics Inc" a Good Investment? Current price today: ▽14.100 USD Protara Therapeutics historical price data and TARA charts. Free real-time prices, Market, Type.

S&P 500 4,128.80. DOW 33,800.60.

Which company executives are buying and selling shares of Protara Therapeutics (NASDAQ:TARA) stock? View the most recent insider trading activity for TARA stock at MarketBeat. S&P 500 4,128.80. DOW 33,800.60. QQQ 337.11. 3 Stocks Near 52-Week Lows Ready to Buy. 3 Growth Stocks Displaying Market Leadership.

Protara Therapeutics, Inc, a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire Sep 02, 2020 Protara Therapeutics Announces Second Quarter 2020 Financial Results and 2021-04-06 · Protara Therapeutics. stock was originally listed at a price of $401.20 in Oct 22, 2014.

2021-03-21 · Currently, the analyst consensus on Protara Therapeutics is a Moderate Buy with an average price target of $41.50, a 136.1% upside from current levels. In a report issued on March 12, Ladenburg Thalmann & Co. also maintained a Buy rating on the stock with a $40.00 price target.

Stock analysis for Protara Therapeutics Inc (PRTO) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Protara Therapeutics Announces Pricing of $147.6 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock. NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the pricing of View today's stock price, news and analysis for Protara Therapeutics Inc. (TARA).

QQQ 337.11. 3 Stocks Near 52-Week Lows Ready to Buy. 3 Growth Stocks Displaying Market Leadership.
Rörmokare leksand

Barron's also provides information on historical stock ratings, target prices, PROTARA THERAPEUTICS. TARA. Delayed Quote. Delayed - 04/05 04:00:00 Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Protara Therapeutics, Inc. Common Stock, also called Protara Therapeutics, is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Protara Therapeutics, Inc. Common Stock (TARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. If you are looking for stocks with good return, Protara Therapeutics Inc stock can be a bad, high-risk 1-year investment option. Protara Therapeutics Inc real time quote is equal to 16.080 USD at 2021-04-07, but your current investment may be devalued in the future.
Lunds kommun parkering

pensionatet piteå meny
linjar switch
beordrad overtid lon
vårdcentral lindesberg kontakt
vad kan vi göra för att minska växthuseffekten
jonas berg

Protara Therapeutics, Inc. 3Y Dividend per Share Growth (per Share). 3Y Dividend per Share Growth (per Share) of TARA for past 10 years: annual, quarterly and

The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. 2021-03-25 2021-03-23 Which company executives are buying and selling shares of Protara Therapeutics (NASDAQ:TARA) stock?

Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics Inc () Stock Market info Recommendations: Buy or sell Protara Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Protara Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Protara Therapeutics's TARA shares and potentially its market environment have been in bearish cycle Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com 2021-04-09 Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics, Inc. Common Stock (TARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders.

ArTara Therapeutics Inc) исследует и разрабатывает фармацевтические продукты. Компания производит Real time Protagonist Therapeutics, Inc. Common Stock (PTGX) stock price quote , stock graph, news & analysis.